Please use this identifier to cite or link to this item:
https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12880
Title: | A narrative review of the literature: The role of biologics and JAK inhibitors in vitiligo |
Author: | Russell, R. Daniel, B. S. |
SWSLHD Author: | Russell, Rhiannon |
Issue Date: | 2024 |
Journal: | Australasian Journal of Dermatology |
Abstract: | Vitiligo is a chronic depigmenting disorder that significantly impacts the quality of life of patients. Though there have been significant advancements in targeted therapies in skin diseases such as psoriasis or eczema, the progress in the treatment of vitiligo has been slow, with minimal studies assessing the effect of biologics, though there has been recent evidence of the effectiveness of JAK inhibition. This paper reviews the published case reports and studies for the use of systemic targeted therapies including biologics and JAK inhibitors in vitiligo. � 2024 The Author(s). Australasian Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Australasian College of Dermatologists. |
ISSN: | 00048380 (ISSN) |
Digital object identifier: | 10.1111/ajd.14353 |
URI: | https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12880 |
Department: | Liverpool Hospital, Department of Dermatology |
Appears in Collections: | Liverpool Hospital |
Files in This Item:
There are no files associated with this item.
Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.